loader
Please Wait
Applying Filters...
menu
    • menu

    List of Certificates of Suitability (CEPs) for r0_cep_2000_002___rev_00 Active Pharmaceutical Ingredient (API) issued by the EDQM. Original Data: EDQM Database

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    Bora Pharmaceuticals- Making success more certain.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Virtual Booth

    Contact Supplier

    Axplora- The partner of choice for complex APIs.

    Virtual Booth

    Contact Supplier

    Fareva is a one-stop-shop for API/HPAPI, OSD & Sterile products, is USFDA, EMA and PMDA-inspected and has multiple NDA & ANDA filings.

    Virtual Booth

    Contact Supplier

    Menu

    Indukern Chemie AG

    EVENTS

    • Webinars & Exhibitions

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 1Indukern Chemie AG Schlieren CH

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass
    Left Arrow
    Right Arrow
    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us

    Indukern Chemie AG Schlieren CH

    Contact Supplier
      • fda
      • EDQM
      • WHO-GMP
      Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
      Post an Enquiry Post an Enquiry
      Flag Switzerland
      Virtual Booth Virtual Booth
      Digital Content Digital Content

      Paracetamol

      Portfolio PDF

      Product Web Link

      Virtual Booth

      Digital Content

      Website

      Corporate PDF

      R0-CEP 2000-002 - Rev 00
      Withdrawn by EDQM F...
      Chemical
      2001-10-22
      2002-10-09
      49
      blank

      01

      Indukern Chemie AG Schlieren CH

      Switzerland
      Discovery on Target
      Not Confirmed
      arrow

      Indukern Chemie AG Schlieren CH

      Switzerland
      arrow
      Discovery on Target
      Not Confirmed
      • fda
      • EDQM
      • WHO-GMP
      Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
      Post an Enquiry Post an Enquiry
      Flag Switzerland
      Virtual Booth Virtual Booth
      Digital Content Digital Content

      Paracetamol

      Certificate Number : R0-CEP 2000-002 - Rev 00

      Status : Withdrawn by EDQM Failure to CEP pro...

      Issue Date : 2001-10-22

      Type : Chemical

      Substance Number : 49

      blank

      Portfolio PDF

      Product Web Link

      Virtual Booth

      Digital Content

      Website

      Corporate PDF

      Looking for Certificates of Suitability (CEPs) for R0-CEP 2000-002 - Rev 00 of Indukern Chemie Ag Schlieren Ch

      Looking for Certificates of Suitability (CEPs) for R0-CEP 2000-002 - Rev 00 of Indukern Chemie Ag Schlieren Ch 1

      20

      Indukern Chemie Ag Schlieren Ch, based in Switzerland, is a pharmaceutical company.

      One of their significant offerings is Paracetamol, supported by a 'Withdrawn by EDQM Failure to CEP procedure' Certificate of Suitability (CEP) with the number R0-CEP 2000-002 - Rev 00

      This Chemical Type CEP, issued on October 22, 2001, remains in force until October 09, 2002, ensuring its reliability within the pharmaceutical industry.

      Substance Number 49 associated with this CEP further emphasizes